Cell Culture Media Market Size, Share Global Analysis Report, 2022 – 2028

Industry Insights

[205+ Pages Report] According to Facts and Factors, the global cell culture media market size was worth around USD 4,716.20 million in 2021 and is estimated to grow to about USD 11,372.175 million by 2028, with a compound annual growth rate (CAGR) of approximately 15.80% over the forecast period. The report analyzes the cell culture media market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the cell culture media market.

Market Overview

The culture media includes several nutrients that support the development, expansion, maintenance, and preservation of microorganisms and other cell types, such as stem cells or other cell lines. Different culture media are offered on the market and can survive and prosper in their incubation conditions. A culture medium is a solid, liquid, or semi-solid created to promote the proliferation of cells to enable the growth of a population of microorganisms or cells. Different cell types are grown in various kinds of mediums. Monoclonal antibody development may benefit from cell culture technologies. These antibodies may be made synthetically in labs using a cell culture medium.

Need and revenue growth are anticipated to be driven by the creation of innovative three-dimensional cell culture techniques and the expanding demand for these techniques in manufacturing vaccines and biopharmaceuticals. Over the projection period, it is predicted that demand for innovative 3D cell culturing techniques and Cell Cultures will increase due to the rising progress of proteomic gene expression and the subsequent creation of novel vaccines and biopharmaceuticals. Other growth in the number of cancer research initiatives and expanded use of gene treatments are additional factors anticipated to fuel demand in this market throughout the projected period.

COVID-19 Impact:

The global healthcare systems are under strain due to the COVID-19 epidemic. Companies during the time experienced personnel issues due to the region-wide shutdown. Humans are to be immunized using cell-based vaccines. Researchers have developed culture-based vaccinations due to increased demand for vaccines and tight safety regulations for innovative vaccines intended to reduce and stop their spread. The government anticipated exploiting cell culture technologies to hasten the creation of vaccines. COVID-19 has a favorable effect on the market for culture and media since vaccines are expedited.

Key Insights:

• As per the analysis shared by our research analyst, the global cell culture media market value will grow at a CAGR of 15.80% over the forecast period.
• In terms of revenue, the global cell culture media market size was valued at around USD 4,716.20 million in 2021 and is projected to reach USD 11,372.17 million by 2028.
• The market has gained momentum due to the growing financing for cell-based research. The study on the global cell culture media market comprehensively evaluates the market.
• By type, the serum-free stem cell media category dominated the market in 2021.
• By application, the biopharmaceutical production category dominated the market in 2021.
• North America dominated the global cell culture media market in 2021.

Growth Drivers

• New methods of cell culture for cell-based vaccinations to drive market growth

Cell culture has emerged as a significant component of vaccine development in the pharmaceutical business. Cell culture technology was employed to create vaccinations against rotavirus, polio, smallpox, hepatitis, rubella, and chickenpox. Cell-based flu vaccinations have also been authorized in the US and other European nations. Previously, the production of vaccinations involved cultivating and extracting viruses in chicken eggs, a labor-intensive operation. However, manufacturing vaccines using cell cultures is a much more effective technique. Shorter lead times and the flexibility to create more vaccines on demand are two of its advantages over conventional production techniques. Additionally, vaccinations made from cell cultures may be kept for a longer time in storage.

Restraints

• Concerns about the ethics of cell biology research to restrain the market growth

Both animal and human cells must be used for cell biology research since both species are used in gene therapy experiments involving gene recombination and stem cell therapies. Additionally, these cells are used to examine the toxicity and pharmacokinetics of drugs that could be detrimental to humans and animals in vivo. Additionally, human embryos are routinely killed in stem cell research studies that use them for medical purposes. In several countries worldwide, moral authorities have created strict regulations to regulate these acts. Due to these ethical concerns and restrictions on the use of cells for research, cell biology research is severely hampered in many countries worldwide. Thus, it is believed that this will restrict consumer demand for cell culture items, such as cell culture media.

Opportunity

• Increased demand from developing nations to create new opportunities in the market

Emerging nations like China, India, Brazil, and Mexico will dominate the cell culture media market throughout the projection. The leading causes of this trend are rising investments in cell biology research and a growing concentration on expanding market participants' presence in developing Asian markets. Due to the rising incidence of chronic illnesses, improved research infrastructure, and supportive laws for cell-based research, several market participants are investing in constructing cell-based research facilities in developing Asian nations. India is also a desirable location for businesses in the cell culture media industry, primarily because of the government's increasing investments in developing high-tech infrastructure for cell-based research, the availability of highly skilled labor, and the advantages of low manufacturing costs.

Segmentation Analysis

The global Cell Culture Media Market is segregated based on type, application, end-user, and region.

Serum-free media, traditional media & salts, stem cell culture media, specialty media, chemically defined media, and other cell culture media are the many types of media available for cell culture. The market's most outstanding share belonged to the serum-free media category. This is explained by the benefits of serum-free media over other media types, such as dependable performance, more significant growth & productivity, better control over physiological response, and a decreased danger of contamination by serum-borne adventitious agents in cell culture.

The bioproduction sector is anticipated to have the highest cell culture market share in 2021. The main drivers of this segment's substantial market share are the use of cell culture goods for research and commercial bioproduction, the rising demand for pharmaceutical and biopharmaceutical products, and the accessibility of funding for research activities.

According to end users, the culture media market is divided into biotech and pharmaceutical companies, academic institutions, and research laboratories. The biotech and pharmaceutical firms sector held the most significant market share and is anticipated to continue to grow throughout the projection period. The culture media market for this category is being driven by the rising usage of single-use technologies, the rise in regulatory approvals for culture-based vaccines, and the presence of several pharmaceutical manufacturers in this industry. The biotechnology organizations hold the highest market share, followed by drug development and drug screening, and they are responsible for the progress in genetic engineering using protein-based biopharmaceuticals. The Cell Culture method also has a variety of uses, including cancer research, gene therapy, and toxicity testing, all of which contribute to the market's expansion.

Report Scope

Recent Developments

• July 2021: The Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, which facilitates the large-scale development and culture of functional natural killer (NK) cells with or without the assistance of feeder cells, was introduced by Thermo Fisher Scientific Inc. (US).
• October 2021: By acquiring cell culture expert Xell AG, Sartorius AG increased its capacity for producing dry powder and liquid media.

Regional Landscape

• Cell culture media market's most significant regional market was in North America in 2021

The North American, European, Asia-Pacific, Latin American, Middle Eastern, and African segments of the worldwide cell culture media market have been identified. The highest market share for cell culture media was held by North America, followed by Europe. The main reasons boosting the growth of the cell culture media market in North America are the rising regulatory approvals for cell culture-based vaccines, expansion in the biotechnology and pharmaceutical sectors, more significant investments in cell-based research, and strong government backing.

In North America, there has been a considerable increase in the demand for cell biology research and cell culture technology. Businesses have begun to invest in novel approaches and advancements in cell culture applications. North America, which held the most significant share of this market, was the area with the most active research and development initiatives about cytological examination for proteomics, genomics, and medicine and vaccine development. During the projection period, it is also predicted that rising demand for biopharmaceuticals would propel regional market expansion.

Competitive Landscape

Key players within the global cell culture media market include 

• InstaReM Pvt. Ltd. 
• Ria Financial Services Ltd. 
• Western Union Holdings Inc. 
• PayPal Holdings Inc. 
• WorldRemit Ltd. 
• Digital Wallet Corporation 
• TransferWise Ltd. 
• Azimo Limited 
• TransferGo Ltd. 
• MoneyGram.

Global Cell Culture Media Market is segmented as follows:

By Type

• Serum-free Media
• CHO Media
• HEK 293 Media
• BHK Media
• VERO Cell Media
• Insect Cell Media
• Serum-free Stem Cell Media
• CAR T-cell Media
• Other Serum-free Media
• Classical Media & Salts
• Stem Cell Culture Media
• Specialty Media
• Chemically defined Media
• Other Cell Culture Media

By Application

• Biopharmaceutical Production
• Monoclonal antibodies
• Vaccine's production
• Other therapeutic proteins
• Diagnostics
• Drug Screening & Development
• Tissue Engineering & Regenerative Medicine
• Cell and gene therapy
• Other tissue engineering & regenerative medicine applications
• Other Applications

By End-User

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Other End Users

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America